Skip to content

Clinical trials

Phase 3 Insulin Resistance trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Phase 3 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20052
20061
20071
20081
20091
20102
20114
20123
20131
20151
20161
20172
20191
20201
20212
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Withdrawn2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gan and Lee Pharmaceuticals, USA3
Brigham and Women's Hospital2
US Department of Veterans Affairs2
University of Colorado, Denver2
AstraZeneca1
Boston Children's Hospital1
Cynthia Calkin1
Glaxo Wellcome1
Mannkind Corporation1
Massachusetts General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance29
Diabetes Mellitus13
Diabetes Mellitus, Type 29
Diabetes Mellitus, Type 17
Obesity4
Hyperlipidemias2
Polycystic Ovary Syndrome2
Arthritis, Rheumatoid1
Bipolar Disorder1
Body Weight1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.